- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Acetylation reprograms MITF target selectivity and residence time ; volume:14 ; number:1 ; day:28 ; month:9 ; year:2023 ; pages:1-15 ; date:12.2023
Nature Communications ; 14, Heft 1 (28.9.2023), 1-15, 12.2023
- Urheber
-
Louphrasitthiphol, Pakavarin
Loffreda, Alessia
Pogenberg, Vivian
Picaud, Sarah
Schepsky, Alexander
Friedrichsen, Hans
Zeng, Zhiqiang
Lashgari, Anahita
Thomas, Benjamin
Patton, E. Elizabeth
Wilmanns, Matthias
Filippakopoulos, Panagis
Lambert, Jean-Philippe
Steingrímsson, Eiríkur
Mazza, Davide
Goding, Colin R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-41793-7
- URN
-
urn:nbn:de:101:1-2024020510151729949298
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Louphrasitthiphol, Pakavarin
- Loffreda, Alessia
- Pogenberg, Vivian
- Picaud, Sarah
- Schepsky, Alexander
- Friedrichsen, Hans
- Zeng, Zhiqiang
- Lashgari, Anahita
- Thomas, Benjamin
- Patton, E. Elizabeth
- Wilmanns, Matthias
- Filippakopoulos, Panagis
- Lambert, Jean-Philippe
- Steingrímsson, Eiríkur
- Mazza, Davide
- Goding, Colin R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rheumatoid arthritis reprograms circadian output pathways
LMO3 reprograms visceral adipocyte metabolism during obesity
Acetate reprograms gut microbiota during alcohol consumption
Thermopriming reprograms metabolic homeostasis to confer heat tolerance
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
Target residence of Cas9: challenges and opportunities in genome editing
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Molecular basis for modulation of the p53 target selectivity by KLF4
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
Rheumatoid arthritis reprograms circadian output pathways
LMO3 reprograms visceral adipocyte metabolism during obesity
Acetate reprograms gut microbiota during alcohol consumption
Thermopriming reprograms metabolic homeostasis to confer heat tolerance
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
Target residence of Cas9: challenges and opportunities in genome editing
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Molecular basis for modulation of the p53 target selectivity by KLF4
Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling
Rheumatoid arthritis reprograms circadian output pathways
LMO3 reprograms visceral adipocyte metabolism during obesity
Acetate reprograms gut microbiota during alcohol consumption
Thermopriming reprograms metabolic homeostasis to confer heat tolerance
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
Target residence of Cas9: challenges and opportunities in genome editing
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Molecular basis for modulation of the p53 target selectivity by KLF4